Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 226.18M | 243.65M | 240.52M | 255.02M | 264.26M |
| Total Depreciation and Amortization | 103.31M | 102.63M | 100.21M | 98.60M | 98.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 158.38M | 164.73M | 155.75M | 154.56M | 127.09M |
| Change in Net Operating Assets | -50.27M | -173.18M | -76.27M | -35.98M | -24.22M |
| Cash from Operations | 437.60M | 337.83M | 420.22M | 472.20M | 465.54M |
| Capital Expenditure | -44.93M | -36.36M | -34.20M | -36.35M | -27.48M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 16.88M | 16.88M | 16.88M |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -1.36M | -489.24M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.62M | -36.82M | 16.12M | 10.24M | 249.86M |
| Cash from Investing | -76.55M | -73.18M | -1.20M | -10.59M | -249.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 29.70M | 32.87M | 35.79M | 43.70M | 39.40M |
| Repurchase of Common Stock | -270.20M | -245.51M | -216.25M | -162.49M | -147.05M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -134.25M | -131.90M | -129.39M | -126.60M | -123.62M |
| Other Financing Activities | -2.04M | -1.97M | -1.65M | -1.85M | -12.03M |
| Cash from Financing | -376.78M | -346.51M | -311.50M | -247.24M | -243.30M |
| Foreign Exchange rate Adjustments | -1.95M | 5.33M | 8.39M | 1.24M | 5.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.68M | -76.54M | 115.91M | 215.61M | -22.06M |